Atlas Trials

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Clinical trial NCT05800665 · RECRUITING

Trial details

NCT number
NCT05800665
Sponsor
Genentech, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Prostate CancerMetastatic Prostate Cancer
Start date
2023-05-02
Primary completion
2027-06-30
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.